Dividend Declaration
RNS Number : 8673K
JPMorgan Claverhouse IT PLC
17 April 2024
 

 

 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC

(the "Company")

 

First quarterly interim dividend

 

 

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

Information disclosed in accordance with DTR 6.1.13

 

 

The Directors of the Company have declared that a first quarterly interim dividend of 8.25 pence per share for the year ending 31st December 2024 will be paid on 3rd June 2024 to shareholders on the register at the close of business on 26th April 2024. The ex-dividend date will be 25th April 2024.

 

As announced in the Annual Report, the Board intends to raise the first three quarterly interim dividends in 2024 to 8.25p per share, from 8.0p per share in the previous financial year, subject to any unforeseen factors and the financial position and performance of the Company at the relevant time.

 

The Company has increased its total annual dividend for 51 consecutive years and the Board's dividend policy remains to seek to increase the dividend each year and, taking a run of years together, to increase dividends at a rate close to, or above, the rate of inflation.

 

The Company offers the option for shareholders to invest their dividend in a Dividend Reinvestment Plan ("DRIP"), which is managed by the Company's registrar. For details on the DRIP, please contact the Company's Registrar, Equiniti Limited.

 

The key dates relating to this dividend are given below:

 

  Ex-dividend date

25th April 2024

  Record date

26th April 2024

  Last date for DRIP election

13th May 2024

  Payment date

3rd June 2024

 

 

17th April 2024

 

 

 For further information:




 Emma Lamb

0800 20 40 20

 JPMorgan Funds Limited


 Company Secretary


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVGPUAWCUPCGQQ